Costs of HER 2 Negative, Hormonal Receptor Positive, Metastatic Breast Cancer (MBC-HR+) Treated with Everolimus (EVE) + Exemestane (EXE) in the Brazilian Private System (BPS): A Real World (RW) and Published Literature Analysis

✍ Scribed by Clark, O.A.C.; Paladini, L.; Engel, T.; Caldas, A.; Valentim, J.

• Book ID: 122201683
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 62 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.472